Virax Biolabs (VRAX) announced that it received a notice from Nasdaq, notifying the company that it is not in compliance with the minimum bid for continued listing on the Nasdaq.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRAX: